Cosmos Health (NASDAQ:COSM) CEO Purchases $161,332.81 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 701,447 shares of Cosmos Health stock in a transaction on Wednesday, June 10th. The stock was acquired at an average price of $0.23 per share, for a total transaction of $161,332.81. Following the purchase, the chief executive officer owned 13,263,361 shares of the company’s stock, valued at approximately $3,050,573.03. This trade represents a 5.58% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, June 11th, Grigorios Siokas bought 218,447 shares of Cosmos Health stock. The stock was acquired at an average price of $0.21 per share, for a total transaction of $45,873.87.

Cosmos Health Stock Performance

COSM stock opened at $0.21 on Monday. Cosmos Health Inc. has a twelve month low of $0.20 and a twelve month high of $1.32. The company has a quick ratio of 0.92, a current ratio of 1.08 and a debt-to-equity ratio of 0.31. The business’s fifty day simple moving average is $0.30 and its two-hundred day simple moving average is $0.40. The firm has a market cap of $13.04 million, a price-to-earnings ratio of -0.33 and a beta of 4.80.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%.The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. Analysts predict that Cosmos Health Inc. will post -0.06 earnings per share for the current year.

Hedge Funds Weigh In On Cosmos Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd grew its position in shares of Cosmos Health by 52.1% during the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after buying an additional 34,117 shares in the last quarter. Citadel Advisors LLC grew its position in shares of Cosmos Health by 133.1% during the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in shares of Cosmos Health by 260.5% during the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock worth $167,000 after buying an additional 241,775 shares in the last quarter. Institutional investors own 12.61% of the company’s stock.

Key Stories Impacting Cosmos Health

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: The company reported annualized sales above $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, and outlined EU expansion plans that could target $7.4 million in revenue and $5.3 million in gross profit by 2028. Article Title
• Positive Sentiment: Cosmos Health announced new contract manufacturing orders totaling 253,657 units, adding to evidence that its Cana subsidiary is seeing steady commercial demand across multiple medicines and pharmaceutical products. Article Title
• Positive Sentiment: CEO Grigorios Siokas made additional open-market share purchases, which investors often view as a signal of management confidence in the company’s outlook. Article Title
• Positive Sentiment: The company signed a letter of intent to acquire Doc Pharma S.A., a GMP manufacturer, a move that could expand assets, production capacity, margins, and its product portfolio if completed. Article Title

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.